Developing a universal vaccine to protect against influenza
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: UNIVERSAL INFLUENZA RESEARCH
This study is all about developing new flu vaccines that can protect you for a longer time and against different types of the flu, and it may involve patients trying out these vaccines to see how well they work and if they're safe.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10391306 on NIH RePORTER |
What this research studies
This research focuses on creating and testing new influenza vaccine candidates that can provide long-lasting and broad protection against various strains of the flu virus. The approach includes analyzing immune responses to inform vaccine design, conducting laboratory tests to evaluate vaccine effectiveness, and developing new methods for vaccine delivery. Patients may be involved in clinical trials to assess the safety and efficacy of these innovative vaccines.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals at high risk for influenza complications, such as the elderly, young children, and those with underlying health conditions.
Not a fit: Patients who are not at risk for influenza or those who have already received effective vaccination may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a universal influenza vaccine that significantly reduces the incidence of flu and its complications.
How similar studies have performed: Previous research has shown promise in developing universal vaccines for influenza, but this approach aims to advance the field further with innovative strategies.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Krammer, Florian — Icahn School of Medicine at Mount Sinai
- Study coordinator: Krammer, Florian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.